4. EBP1 |
Eukaryotic translation initiation factor 4E-binding protein 1 |
5-HT1A |
Serotonin 1A receptor |
AKT |
Protein kinase B |
CBD |
Cannabidiol |
CB1 and CB2 |
Cannabinoid receptor 1 and 2 |
CCL3 |
Chemokine (C-C motif) ligand 3 |
CDK |
Cyclin-dependent kinase |
CSS |
Combination sensitivity score |
DOC |
Docetaxel |
DOX |
Doxorubicin |
EGFR |
Epidermal growth factor receptor |
ER+/− |
Oestrogen receptor-positive/negative |
ETC |
Electron transport chain |
FC |
Fold change |
GM-CSF |
Granulocyte-macrophage colony-stimulating factor |
GPR55 |
G protein-coupled receptor 55 |
Id1 |
DNA-binding protein inhibitor ID-1 |
HER2+ |
Human epidermal growth factor receptor 2 positive |
HER3 |
Human epidermal growth factor receptor 3 |
HGNC |
HUGO Gene Nomenclature Committee |
MCM |
Minichromosome maintenance proteins |
MIP-2 |
Macrophage Inflammatory Protein-2 |
mTOR |
Mechanistic target of rapamycin |
NF-κB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
ROS |
Reactive oxygen species |
PPAR-γ |
Peroxisome proliferator-activated receptor gamma |
PTX |
Paclitaxel |
SN−38 |
7-Ethyl-10-hydroxycamptothecin |
TAM |
Tumour-associated macrophage |
TRPVs |
Family of transient receptor potential (TRP) ion channel |
TNBC |
Triple-negative breast cancer |
VIN |
Vinorelbine |